-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
June 01, 2018 - Measure Number
0232
1.C. … c. Care Setting – other – please specify: No.
d. … data abstracted for this study did not include indicators of special health
care needs.
18
7.C. … in
Michigan; medical records were abstracted using the EHR system at each participating site.
11.C. … Electronically display all the information for a test report specified at 42 CFR
26
493.1291(c)
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-fullreport.pdf
April 02, 2018 - Measure Number
0230
1.C. … c. Care Setting – other – please specify: Yes; emergency department.
d. … records data abstracted for this study did not include indicators of special health
care needs.
7.C. … Medical records were abstracted using the EHR system at each participating site.
11.C. … Electronically display all the information for a test report specified at 42 CFR
493.1291(c)(1) through
-
www.ahrq.gov/policymakers/chipra/overview/background/appendix-a8.html
December 01, 2009 - Format and conduct of consensus development conferences: a multi-nation comparison, in Goodman C and
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/prevention-of-opioid-user-disorder-ehc-tech-brief.pdf
May 14, 2021 - health consequences, including localized
and systemic infections (e.g., cellulitis, endocarditis, HIV, hepatitis … c. … Singh S, Clarke C, Lawendy A, et al. … McCracken LM, Boichat C, Eccleston C. … Barber C, Gagnon D, Fonda J, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_2012-12-10.pdf
January 01, 2012 - The delivery system (which is also being evaluated for delivering drugs for hepatitis and
weight loss … c=101911&p=irol-
newsArticle&ID=1653756.
47. … c=101911&p=irol-newsArticle&ID=1653756
http://phx.corporate-ir.net/phoenix.zhtml? … Yang B, D'Vaz R, Negulescu C, et al. … Phend C. ADA: anti-VEGF 'impressive' in
sharpening vision. [internet].
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_A.PDF
January 01, 2003 - : D&C,CONIZATION&RADIO-IMPLNT,MALIG W MCC <= 10 **.**
3640: D&C,CONIZATION EXC FOR MALIGNANCY W/O CC … 120 0.02
3641: D&C,CONIZATION EXC FOR MALIGNANCY W CC 57 0.01
3642: D&C,CONIZATION EXC FOR MALIGNANCY … /OR D&C W MCC <= 10 **.**
3750: VAG DEL W O.R EX STERIL &/OR D&C W/O CC 38 0.00
3751: VAG DEL W O.R … W/O CC 315 0.04
3801: ABORTION W/O D&C W CC 76 0.01
3802: ABORTION W/O D&C W MCC <= 10 **.**
3810: … ABORTN W D&C,ASP CURETT,HYSTEROT W/O CC 476 0.06
3811: ABORTN W D&C,ASP CURETT,HYSTEROT W CC 120 0.02
-
www.ahrq.gov/research/findings/final-reports/ptfamilyscan/ptfamily3.html
July 01, 2018 - Appendix A: Draft Key Informant Interview Protocol
Appendix B: Summary of Search Terms
Appendix C: … medical errors." 24 Likewise, during cognitive testing of AHRQ's Five Steps to Safer Health Care , c … c. Five Steps to Safer Health Care.
-
www.ahrq.gov/research/findings/final-reports/ptflow/section2.html
July 01, 2018 - Successfully Used by Hospitals to Improve Patient Flow
Appendix B: Implementation Plan Template
Appendix C:
-
www.ahrq.gov/patient-safety/quality-resources/tools/chtoolbx/measures/measure-6.html
November 01, 2017 - Bethell, C, Reuland CH, Halfon N, Schor E.
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/PublicSummaryStats_KID_2006_Severity.PDF
January 01, 2006 - 1227 0.04
542: Vag del w cmp proc ex ster/D&C 5268 0.17
544: D&C, asp curet, hysterot-OB 2797 0.09 … *.**
3640: D&C,CONIZATION EXC FOR MALIGNANCY WO CC 83 0.00
3641: D&C,CONIZATION EXC FOR MALIGNANCY … &/OR D&C W MCC 15 0.00
3750: VAG DEL W O.R EX STERIL &/OR D&C WO CC 89 0.00
3751: VAG DEL W O.R EX … STERIL &/OR D&C W CC 71 0.00
3752: VAG DEL W O.R EX STERIL &/OR D&C W MCC <= 10 **.**
3760: POSTPART … W D&C,ASP CURETT,HYSTEROT WO CC 1823 0.06
3811: ABORTN W D&C,ASP CURETT,HYSTEROT W CC 480 0.02
3812
-
hcup-us.ahrq.gov/tech_assist/data_query/Methods_Community_Statistics20230207.pdf
December 01, 2022 - u=https-3A__claritas360.claritas.com_mybestsegments_&d=DwMFAg&c=jf_iaSHvJObTbx-siA1ZOg&r=2qQwVBn6hVQgR7RNjEA4Tc2Yt-lUl674IM-sBUsuioI … 535.30 Alcohol
Alcoholic gastritis, with hemorrhage 535.31 Alcohol
Fatty liver 571.0 Alcohol
Alcohol hepatitis
-
www.ahrq.gov/research/findings/final-reports/stpra/stpraapd2.html
April 01, 2018 - Database Analysis
Appendix C. Site Visit Protocol
Appendix D. … Use betadine for C-section etc if not enough time to dry.
-
www.ahrq.gov/research/findings/final-reports/stpra/stpra4.html
April 01, 2018 - Database Analysis
Appendix C. Site Visit Protocol
Appendix D.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/hbSopN6uA9u-4EQuKtRGDP
October 01, 2011 - Egger M, Davey Smith G, Schneider M, Minder C. … Jeffery RW, Wing RR, Thorson C, Burton LR, Raether C, Harvey J, et al. … Berne C; Orlistat Swedish Type 2 diabetes Study Group. … Hauptman J, Lucas C, Boldrin MN, Collins H, Segal KR. … Kirk EP, Jacobsen DJ, Gibson C, Hill JO, Donnelly JE.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research.pdf
September 01, 2014 - c. With non sex-specific etiologies
1
d. … c. With non sex-specific etiologies?
d. … White C, Ip S, McPheeters M, et al. … C-2
Appendix D. Inclusion Criteria
Table D1. … Not SR
Getliffe K, Fader M, Allen C, et al.
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - Suggested Citation
Meadows G, Moesel C, Sebastian S, et al. … Consultation on the Pain Management Summary CDS and its placement into the
clinical workflow
c. … c.,,tloM
• Non.Opioid M-ldlc.it1t,n5
Pcmazocloo SO MG Oral Tablet Statement 2018-Mor-15
• Nol"I-Ph … Risk Considerallons (7) C)
e Mo!>t R.Pt.11nt MME
• Urine D11J9 S-c:r.•na
O Bcn.zodl.'
-
digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-pilot-final-report.pdf
September 01, 2018 - Suggested Citation
Meadows G, Moesel C, Sebastian S, et al. … Consultation on the Pain Management Summary CDS and its placement into the
clinical workflow
c. … c.,,tloM
• Non.Opioid M-ldlc.it1t,n5
Pcmazocloo SO MG Oral Tablet Statement 2018-Mor-15
• Nol"I-Ph … Risk Considerallons (7) C)
e Mo!>t R.Pt.11nt MME
• Urine D11J9 S-c:r.•na
O Bcn.zodl.'
-
meps.ahrq.gov/data_files/publications/mr3/mr3.pdf
September 01, 1998 - TYPE NAME RH HS PM BQ IN
CR ELAINE BRAZIL C RDY C RDY RDY
CR JACKIE CALDRON C RDY C RDY RDY
CR DONALD … FREUD C RDY C RDY RDY
CR PEGGY LACEY C RDY C RDY RDY
SAMPLED ADMISSION DATE: 09/11/93 AVAILABLE RESULT … Bethel J, Flyer P, Wolters C. … Tourangeau K, Vincent C, Anderson S, et al. … X X X X
Sexually transmitted diseases X X
Tuberculosis X X X
Urinary tract infection X X X X
Viral hepatitis
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Wezro6zTSfAWxCrneF-nxB
May 01, 2005 - The risk factors examined included age less than 20 years, marital
status, history of STD or hepatitis … Sloan NL, Winikoff B, Haberland N, Coggins C,
Elias C. … Banikarim C, Chacko MR, Wiemann CM, Smith
PB. … Todd CS, Haase C, Stoner BP. … Gift T, Walsh C, Haddix A, Irwin KL.
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-145-materials-v-a.pdf
June 25, 2014 - c. … is increased too rapidly; de
crease in appetite; increase in suicidal
thoughts (less common); and hepatitis … Chan E, Zhan C, Homer CJ. … Homer C, Klatka K, Romm D, et al. … D
D
C
C
D
*
Evidence classification/rating scheme described at end of this document Page 2